Clazakizumab in late antibody-mediated rejection: study protocol of a randomized controlled pilot trial.
Eskandary F, Dürr M, Budde K, Doberer K, Reindl-Schwaighofer R, Waiser J, Wahrmann M, Regele H, Spittler A, Lachmann N, Firbas C, Mühlbacher J, Bond G, Halloran PF, Chong E, Jilma B, Böhmig GA.
Eskandary F, et al. Among authors: durr m.
Trials. 2019 Jan 11;20(1):37. doi: 10.1186/s13063-018-3158-6.
Trials. 2019.
PMID: 30635033
Free PMC article.